Accelerating Cancer Cures Advisory Committee
The Accelerating Cancer Cures Advisory Committee is comprised of senior oncology leaders in the collaborating companies. A valuable resource for Damon Runyon Clinical Investigators, committee members are available for discussions and advice about the process of translating discoveries into therapeutics.
Richard Gaynor, MD
Chair
Vice President, Cancer Research/Clinical Investigation
Eli Lilly and Co.
Christopher A. Slapak, MD
Distinguished Lilly Scholar
Eli Lilly and Co.
Rajesh Chopra, MD, PhD
Vice President, Translational Development
Celgene Corporation
Tom Daniel, MD
President of Research
Celgene Corporation
Sandra Horning, MD
Senior Vice President, Global Head, Clinical Development Hematology & Oncology
Genentech, Inc.
Nancy Valente, MD
Senior Group Director/ Franchise Head of B-Cell & Hematology
Genentech, Inc.
Gary Gilliland, MD, PhD
Senior Vice President, Franchise Head, Oncology
Merck & Co., Inc.
Eric Rubin, MD
Vice President & Therapeutic Area Head Oncology Clinical Development
Merck & Co., Inc.
Karen J. Ferrante, MD
Chief Medical Officer
Millennium: The Takeda Oncology Company
Mace Rothenberg, MD
Senior Vice President, Clinical Development and Medical Affairs
Pfizer, Inc.